Company / FCF Margin
Apyx Medical Corp FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-17.3%
FY2025
5-year range
-60.1% / -17.3%
FY2021-FY2025
Trend
+55.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -47.8% to -17.3% over the past 2 years.
Based on SEC 10-K filings.
-17.3% in FY2025 with a 5-year CAGR of +52.8%.
Improved from -47.8% to -17.3% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +30.6pp
- 5-Year Change
- +52.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 55.8% year-over-year.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -17.3% | +55.8% |
| FY2024 | -39.0% | +18.4% |
| FY2023 | -47.8% | +0.0% |
| FY2022 | -47.8% | +20.4% |
| FY2021 | -60.1% | +14.2% |
| FY2020 | -70.0% | -65.6% |
| FY2019 | -42.3% | -19.4% |
| FY2018 | -35.4% | -68.4% |
| FY2017 | -21.0% | -456.3% |
| FY2016 | -3.8% | +71.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026